INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27 | -12.9% | 844 | +10.2% | 0.01% | -14.3% |
| Q2 2023 | $31 | +10.7% | 766 | +2.4% | 0.01% | 0.0% |
| Q1 2023 | $28 | +12.0% | 748 | +5.4% | 0.01% | 0.0% |
| Q4 2022 | $25 | -99.9% | 710 | +24.8% | 0.01% | -30.0% |
| Q3 2022 | $32,000 | 0.0% | 569 | -7.2% | 0.01% | +11.1% |
| Q2 2022 | $32,000 | -27.3% | 613 | +1.0% | 0.01% | -30.8% |
| Q1 2022 | $44,000 | -45.7% | 607 | -11.8% | 0.01% | -50.0% |
| Q4 2021 | $81,000 | -6.9% | 688 | +5.5% | 0.03% | -50.9% |
| Q3 2021 | $87,000 | -37.0% | 652 | -23.3% | 0.05% | -44.2% |
| Q2 2021 | $138,000 | +32.7% | 850 | -34.3% | 0.10% | +20.3% |
| Q1 2021 | $104,000 | +46.5% | 1,293 | -0.6% | 0.08% | +43.6% |
| Q4 2020 | $71,000 | +86.8% | 1,301 | -31.3% | 0.06% | +77.4% |
| Q3 2020 | $38,000 | 0.0% | 1,894 | +4.2% | 0.03% | -3.1% |
| Q2 2020 | $38,000 | +72.7% | 1,817 | 0.0% | 0.03% | +39.1% |
| Q1 2020 | $22,000 | -21.4% | 1,817 | -3.2% | 0.02% | -59.6% |
| Q4 2019 | $28,000 | +27.3% | 1,878 | +13.5% | 0.06% | +18.8% |
| Q3 2019 | $22,000 | -21.4% | 1,655 | -2.1% | 0.05% | -29.4% |
| Q2 2019 | $28,000 | +55.6% | 1,691 | +60.9% | 0.07% | -20.9% |
| Q1 2019 | $18,000 | – | 1,051 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |